Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vasopressin vs Tranexamic Acid in Abdominal Hysterectomy
NCT06290596Phase 4Not yet recruiting
- Sponsor
- Al-Azhar University
- Start
- Apr 2024
- Primary completion
- Oct 2024
- Modality
- Peptides, Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of vasopressin and tranexamic acid (3 arms), sponsored by Al-Azhar University. Primary endpoint: Blood loss at 24 hours. Planned start Apr 2024; status: not yet recruiting.
02
Drugs
vasopressintranexamic acid
Beyond the preview
Go deeper on NCT06290596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06290596.